Bayesian borrowing from historical control data in a vaccine efficacy trial

被引:0
作者
Peng, Lin [1 ,2 ]
Jin, Jing [3 ]
Chambonneau, Laurent [4 ]
Zhao, Xing [1 ,2 ]
Zhang, Juying [1 ,2 ]
机构
[1] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China
[3] Biostat Sci Sanofi, Beijing, Peoples R China
[4] Biostat Sci Sanofi, Marcy Letoile, France
关键词
Bayesian approach; historical data borrowing; power prior; vaccine efficacy trial; RESPIRATORY SYNCYTIAL VIRUS; PRIOR DISTRIBUTIONS; REDUCES HOSPITALIZATION; VARIANCE PARAMETERS; CLINICAL-TRIALS; POWER PRIOR; PRIORS; PALIVIZUMAB; INFORMATION;
D O I
10.1002/pst.2313
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the context of vaccine efficacy trial where the incidence rate is very low and a very large sample size is usually expected, incorporating historical data into a new trial is extremely attractive to reduce sample size and increase estimation precision. Nevertheless, for some infectious diseases, seasonal change in incidence rates poses a huge challenge in borrowing historical data and a critical question is how to properly take advantage of historical data borrowing with acceptable tolerance to between-trials heterogeneity commonly from seasonal disease transmission. In this article, we extend a probability-based power prior which determines the amount of information to be borrowed based on the agreement between the historical and current data, to make it applicable for either a single or multiple historical trials available, with constraint on the amount of historical information to be borrowed. Simulations are conducted to compare the performance of the proposed method with other methods including modified power prior (MPP), meta-analytic-predictive (MAP) prior and the commensurate prior methods. Furthermore, we illustrate the application of the proposed method for trial design in a practical setting.
引用
收藏
页码:815 / 835
页数:21
相关论文
共 29 条
  • [1] [Anonymous], 2005, EXACT CALCULATION BE
  • [2] Modified power prior with multiple historical trials for binary endpoints
    Banbeta, Akalu
    van Rosmalen, Joost
    Dejardin, David
    Lesaffre, Emmanuel
    [J]. STATISTICS IN MEDICINE, 2019, 38 (07) : 1147 - 1169
  • [3] A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods
    Bennett, Maxine
    White, Simon
    Best, Nicky
    Mander, Adrian
    [J]. PHARMACEUTICAL STATISTICS, 2021, 20 (03) : 462 - 484
  • [4] Bennett MS., 2018, IMPROVING EFFICIENCY
  • [5] Evaluating water quality using power priors to incorporate historical information
    Duan, YY
    Ye, KY
    Smith, EP
    [J]. ENVIRONMETRICS, 2006, 17 (01) : 95 - 106
  • [6] Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach
    Feisst, Manuel
    Krisam, Johannes
    Kieser, Meinhard
    [J]. PHARMACEUTICAL STATISTICS, 2020, 19 (05) : 662 - 678
  • [7] Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
    Feltes, TF
    Cabalka, AK
    Meissner, C
    Piazza, FM
    Carlin, DA
    Top, FH
    Connor, EM
    Sondheimer, HM
    [J]. JOURNAL OF PEDIATRICS, 2003, 143 (04) : 532 - 540
  • [8] Food and Drug Administration, 2010, Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
  • [9] Food and Drug Administration, 2020, GUID IND INT FOOD DR
  • [10] Prior distributions for variance parameters in hierarchical models(Comment on an Article by Browne and Draper)
    Gelman, Andrew
    [J]. BAYESIAN ANALYSIS, 2006, 1 (03): : 515 - 533